Rocket Pharmaceuticals, Inc.
RCKT
$7.59
-$0.29-3.68%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.12% | -7.79% | -6.00% | -6.38% | 10.59% |
| Total Depreciation and Amortization | 22.02% | 35.82% | 36.97% | 34.73% | 8.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 80.80% | 5.18% | 17.18% | 14.09% | -25.82% |
| Change in Net Operating Assets | -103.28% | 147.58% | -18.38% | 39.04% | 12,777.65% |
| Cash from Operations | -60.00% | 8.83% | -5.81% | 1.22% | 47.63% |
| Capital Expenditure | 93.35% | 65.89% | 53.14% | 32.50% | -54.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 72.41% | 52.16% | 62.93% | 209.98% | 8.19% |
| Cash from Investing | 73.10% | 63.55% | 78.25% | 195.41% | -29.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 46,664.45% | -99.91% | 740.66% | -93.55% | -99.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 46,664.45% | -99.91% | 740.66% | -93.55% | -99.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 157.75% | -85.05% | 117.10% | 72.82% | -202.23% |
